Account
Case Studies
26.04.2023
Our client wanted to gain an understanding

Our client wanted to gain an understanding of payer willingness to pay and determine the likely clin...

Read more
Case Studies
26.04.2023
Biosimilar country pricing and market access

Our client wanted to gain a better understanding of current and forthcoming policy measures affectin...

Read more
Case Studies
26.04.2023
Partnered with a biosimilar company

Development and submission of payer communication materials and pricing and reimbursement dossiers f...

Read more
News
25.04.2023
PMA Insights: Week 17

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Publications
21.04.2023
ISPOR US 2023: How do the reimbursement opportunit...

Our research compares and contrasts the reimbursement landscapes of digital health applications (DHA...

Read more
Case Studies
21.04.2023
Securing the optimum price launch price

Our client sought our expertise to support them in the development and submission of the optimum pri...

Read more
Articles
20.04.2023
EU HTA and what it means for manufacturers

Oncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...

Read more
Insider Insights
22.03.2023
More clarity given on the proposed changes to comb...

The German government has released information regarding the 20% discounts to combination products e...

Read more
Insider Insights
09.03.2023
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
09.03.2023
The Financial Stabilisation Act is unlikely to off...

DAK-Gesundheit claim that cost saving measures imposed by the GVK Financial Stabilisation Act are un...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.